Glioblastoma: all 1,951 studies
Page 10 of 20. Open to participants first (457), then studies with results posted, then the rest; newest registration first within each.
- Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS TumorsActive, not recruitingNCT05835687Phase 1
- [18F]FPIA PET-CT in Glioblastoma Multiforme (GBM)CompletedNCT05801159
- Identification of Treatment Concentrations of Defactinib or VS-6766 for the Treatment of Patients With GlioblastomaActive, not recruitingNCT05798507Early Phase 1
- Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA StudyActive, not recruitingNCT05781321Phase 2
- Dexamethasone and Azeliragon for Management of Post-Resection Cerebral Edema in Patients with GlioblastomaWithdrawnNCT05773664Phase 1
- Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGGTerminatedNCT05773326Early Phase 1
- Modulation of Ciliogenesis in Glioma Stem CellsCompletedNCT05772767Not applicable
- Grafts of GSCs Into Brain Organoids for Testing Anti-invasion DrugsStatus unknownNCT05772741Not applicable
- Biomolecular Analysis for Predicting Response to RegorafenibCompletedNCT05759195Not applicable
- Immuno-Positron Emission Tomography (PET)-Glioma Study, a Proof-of-principle Imaging StudyActive, not recruitingNCT05753995Not applicable
- Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated GlioblastomaActive, not recruitingNCT05743595Phase 1
- Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent GlioblastomaActive, not recruitingNCT05739942Phase 1
- Treatment of Recurrent Glioblastoma With Fractionated Radiotherapy Combined With CadonilimabStatus unknownNCT05737368Phase 1
- Studying the Safety, Efficacy, and Pharmacokinetic Characteristics of BNCT in Patients With Recurrent High-grade GliomasTerminatedNCT05737212Phase 1/2
- A Dose-escalation Clinical Study of Intraoperative Photodynamic Therapy of GlioblastomaActive, not recruitingNCT05736406Phase 1/2
- Supramarginal Resection in Glioblastoma Guided by Artificial IntelligenceCompletedNCT05735171Not applicable
- UNIty-Based MR-Linac Guided Adaptive RadioThErapy for High GraDe Glioma-3 (UNITED-3)Active, not recruitingNCT05720078Not applicable
- Neoadjuvant Chemoimmunotherapy in Recurrent GlioblastomaStatus unknownNCT05700955Phase 1
- Study to Evaluate the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of ITI-1001 In Patients With Newly Diagnosed Glioblastoma (GBM)CompletedNCT05698199Phase 1
- GRETeL: Tumor Response to Standard Radiotherapy and TMZ Patients With GBMSuspendedNCT05695976
- Etoposide Plus Cisplatin Compared With Temozolomide in Patients With GlioblastomaStatus unknownNCT05694416Phase 2
- Brain Imaging to Predict Toxicity in Elderly Patients After RadiotherapyCompletedNCT05671016
- Reirradiation and Niraparib in Patients With Recurrent GlioblastomaWithdrawnNCT05666349Phase 1
- A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed GlioblastomaActive, not recruitingNCT05664243Phase 1/2
- LITT Combined With Early Use of Temozolomide for Recurrent GlioblastomasStatus unknownNCT05663125Phase 1/2
- Azeliragon and Chemoradiotherapy in Newly Diagnosed GlioblastomaCompletedNCT05635734Phase 1/2
- ARISTOCRAT: Blinded Trial of Temozolomide +/- CannabinoidsActive, not recruitingNCT05629702Phase 2
- CAR T Cells in Patients With MMP2+ Recurrent or Progressive GlioblastomaTerminatedNCT05627323Phase 1
- 11C-methionine in Diagnostics and Management of Glioblastoma Multiforme Patients (GlioMET)CompletedNCT05608395Phase 2
- Methimazole in Patients With Progressive GlioblastomaSuspendedNCT05607407Phase 2
- Safety and Efficacy of TRPP Therapy in Glioblastoma MultiformeStatus unknownNCT05589961Early Phase 1
- UNITy-BasED MR-Linac Adaptive Simultaneous Integrated Hypofractionated Boost Trial for High Grade Glioma in the ElderlyActive, not recruitingNCT05565521Phase 2
- 89Zr-girentuximab for PET Imaging of CAIX Positive Solid TumorsTerminatedNCT05563272Phase 2
- Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade GliomaActive, not recruitingNCT05561374Phase 1
- RMC-5552 Monotherapy in Adult Subjects With Recurrent GlioblastomaTerminatedNCT05557292Phase 1
- Glioblastoma Evaluation for Heterogeneity In RadioseNsitivityStatus unknownNCT05556382
- Treatment of Recurrent GBM With APG-157 Via Expanded AccessNo longer availableNCT05551013
- A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid TumorsCompletedNCT05538572Phase 1
- Investigational Imaging Technique During Brain SurgerySuspendedNCT05513859Not applicable
- First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid TumoursActive, not recruitingNCT05495295Phase 1
- A Phase I Clinical Trial of Bevacizumab InjectionCompletedNCT05476341Phase 1
- Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent GlioblastomaActive, not recruitingNCT05465954Phase 2
- Surgical Pembro +/- Olaparib w TMZ for rGBMActive, not recruitingNCT05463848Phase 2
- 131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2)Active, not recruitingNCT05450744Phase 1
- Phase 2 Study of CAN008 in Subjects With GBMStatus unknownNCT05447195Phase 2
- Study of Tinostamustine for Adjuvant Treatment of GlioblastomaCompletedNCT05432375Early Phase 1
- Effect of stRess and exeRcize on the Outcome After Chemo-RadiationCompletedNCT05431348
- Golden Halo, Static Magnetic and Electric Field Device, in Recurrent GlioblastomaWithdrawnNCT05410301Not applicable
- IRD at Admission Predicts Survival of GBM Patients - a Prospective Pilot StudyCompletedNCT05402241
- Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain TumorsCompletedNCT05383872Not applicable
- A Study to Determine How BI 907828 (Brigimadlin) is Taken up in the Tumor (Phase 0) and to Determine the Highest Dose of BI 907828 (Brigimadlin) That Could be Tolerated (Phase 1a) in Combination With Radiation Therapy in People With a Brain Tumor Called GlioblastomaCompletedNCT05376800Phase 1
- BIOhabitats: Biological Validation of Vascular Habitats Within Astrocytoma Grade 4 at Molecular, Cellular, and Histopathological LevelsCompletedNCT05375318
- IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult GlioblastomaActive, not recruitingNCT05353530Phase 1
- GammaTile and Stupp in Newly Diagnosed GBMActive, not recruitingNCT05342883Phase 4
- Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens for Patients With Recurrent GlioblastomaWithdrawnNCT05341947Phase 1
- The Safety Study of Autologous TILs Therapy for Patients With Glioblastoma Multiforme.Status unknownNCT05333588Early Phase 1
- Fluorescence, Light-microscopy, Ultrasound Integrated / Intraoperative Diagnosis to MAXimise ResectionStatus unknownNCT05330559
- A Study of Intra-tumoral Administered MTX110 in Patients With Recurrent GlioblastomaTerminatedNCT05324501Phase 1
- Effectiveness of MR-guided LITT Therapy in Irresectable Glioblastoma (EMITT)Active, not recruitingNCT05318612Phase 3
- Safety and Efficacy of Different Administration Sequences of L19TNF With Lomustine in Glioblastoma at First ProgressionWithdrawnNCT05304663Phase 1
- Safety and Feasibility of MR-guided Laser Thermal Ablation of Brain LesionsCompletedNCT05296122Not applicable
- Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid TumorsTerminatedNCT05275478Phase 1/2
- Safety and Efficacy Study of Anti-B7-H3 CAR-T Cell Therapy for Recurrent GlioblastomaActive, not recruitingNCT05241392Phase 1
- Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of GlioblastomaActive, not recruitingNCT05236036Phase 1
- ALBATROSS Study: International Multicenter Study for Prospective Validation of Imaging Biomarkers Calculated at Vascular Habitats of High-grade GliomasCompletedNCT05229198
- Safety and Tolerability of Fb-PMT in Recurrent GlioblastomaActive, not recruitingNCT05226494Phase 1
- A Study to Evaluate ERAS-801 in Patients With Recurrent Glioblastoma (THUNDERBBOLT-1)Active, not recruitingNCT05222802Phase 1
- CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild TypeWithdrawnNCT05218408Phase 1/2
- Irinotecan And Bevacizumab Combined With Re-radiotherapy in Recurrent GlioblastomaStatus unknownNCT05201326Phase 1
- GX-I7 in Combination With Bevacizumab in Recurrent Glioblastoma (GBM) PatientsActive, not recruitingNCT05191784Phase 2
- Chlorpromazine and Standard of Care in GlioblastomaCompletedNCT05190315Phase 1
- A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With GlioblastomaCompletedNCT05187624Phase 1
- Glioblastoma Targeted Treatment Option Maximization by WGSCompletedNCT05186064Not applicable
- Paxalisib With a High Fat, Low Carb Diet and Metformin for GlioblastomaCompletedNCT05183204Phase 2
- AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma PatientsActive, not recruitingNCT05182905Early Phase 1
- Differentiation Between Healthy Cerebral Tissue and Tumor Tissue Using a Tissue Sensing InstrumentCompletedNCT05171127
- CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBMActive, not recruitingNCT05168423Phase 1
- SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE)Active, not recruitingNCT05163080Phase 2
- The BurnAlong Pilot Study for Adolescent and Young Adult Cancer SurvivorsCompletedNCT05131815Not applicable
- NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid TumorsStatus unknownNCT05131763Phase 1
- Combination of Stereotactic Radiosurgery and Enhanced Immunotherapy for Recurrent Glioblastomas(inSituVac2)(CSREIG)Status unknownNCT05131711Phase 1/2
- Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)Active, not recruitingNCT05120284Phase 2
- Study to Evaluate the Safety and Efficacy of ASC40 Tablets in Combination With Bevacizumab in Subjects With rGBMActive, not recruitingNCT05118776Phase 3
- A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.Active, not recruitingNCT05109728Phase 1
- Nk Cell Therapy for Recurrent Glioblastoma Multiform PatientsStatus unknownNCT05108012Phase 1
- Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated GlioblastomaActive, not recruitingNCT05095376Phase 3
- Natural Progesterone for the Treatment of Recurrent GlioblastomaTerminatedNCT05091866Early Phase 1
- Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent GliomaActive, not recruitingNCT05076513Early Phase 1
- A Trial of Neoadjuvant Therapy in Patients With Newly Diagnosed GlioblastomaTerminatedNCT05074992Phase 2
- The Efficacy and Safety of Brain-targeting Immune Cells (EGFRvIII-CAR T Cells) in Treating Patients With Leptomeningeal Disease From Glioblastoma. Administering Patients EGFRvIII -CAR T Cells May Help to Recognize and Destroy Brain Tumor Cells in PatientsStatus unknownNCT05063682Phase 1
- Brain Tumor Intraoperative Ultrasound DatabaseCompletedNCT05062772
- Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MRWithdrawnNCT05054400Early Phase 1
- A Study to Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma MultiformeActive, not recruitingNCT05053880Phase 1/2
- Quality of Life and Patient Needs in Advanced High Grade GliomasCompletedNCT05039346
- Atezolizumab and Cabozantinib for the Treatment of Recurrent GlioblastomaActive, not recruitingNCT05039281Phase 1/2
- Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma.Status unknownNCT05033587Phase 2
- Study of DSP-0390 in Patients With Recurrent High-Grade GliomaActive, not recruitingNCT05023551Early Phase 1
- Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or GliosarcomaWithdrawnNCT05017610Early Phase 1
- Physical Training in Glioblastoma Patients During Cytotoxic TherapyCompletedNCT05015543Not applicable
- Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM PatientsCompletedNCT04998864